摘要
癌症是心脏病后世界主要死亡原因,涉及原发部位细胞生长和可能扩散到身体其他部位的异常。肿瘤具有高度的异质性,由具有不同特征的细胞亚群组成。其中,癌症干细胞(CSC)生态位在驱动肿瘤的扩散中起着至关重要的作用,并被认为提供了治疗耐药性。CSC是一种罕见的特殊癌症细胞群,具有高致瘤能力、自我更新和分化能力。CSC不仅与高肿瘤起始活性有关,而且还与化疗耐药性、转移、上皮细胞向间充质细胞的转化和复发有关。此后,需要新的靶向CSC的治疗策略来改善长期的临床结果。文献支持海洋天然化合物具有抗氧化、抗有丝分裂、抗炎、抗生素和抗癌活性的证据。在这篇综述中,我们将深入了解选定的海洋天然产物作为具有抗癌特性的生物活性化合物来源来靶向CSC的相关性,这可能有助于新的抗癌治疗策略的发展。
关键词: 藻类、转移、静止、抗性、海绵、干性,肿瘤微环境。
Current Medicinal Chemistry
Title:Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells
Volume: 28 Issue: 22
关键词: 藻类、转移、静止、抗性、海绵、干性,肿瘤微环境。
摘要: Cancer is the world’s leading cause of death after heart diseases and involves abnormal cell growth at a primary site and the potential to spread to other parts of the body. Tumors are highly heterogeneous and consist of subgroups of cells with distinct characteristics. Of these, the cancer stem cells (CSC) niche plays a crucial role in driving the spread of the tumor and are thought to provide treatment resistance. CSC is a rare special population of cancer cells exhibiting high tumorigenic properties together with self-renewal and differentiation capability. CSC is not only linked with high tumor-initiating activity, but is also implicated in chemotherapeutic resistance, metastasis, epithelial to mesenchymal transition, and recurrence. Thereafter, novel therapeutic strategies targeting CSC are in need to improve long-term clinical outcomes. The literature supports the evidence that marine natural compounds can exhibit antioxidant, antimitotic, anti-inflammatory, antibiotic as well as anticancer activity. In this review, we will provide an insight into the relevance of selected marine natural products as a source of bioactive compounds with anti-cancer properties to target CSC, which may benefit the development of novel anti-cancer therapeutic strategies.
Export Options
About this article
Cite this article as:
Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells, Current Medicinal Chemistry 2021; 28 (22) . https://dx.doi.org/10.2174/0929867327666200320155053
DOI https://dx.doi.org/10.2174/0929867327666200320155053 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Genome-wide Association Analysis in Four Populations Reveals Strong Genetic Heterogeneity For Birth Weight
Current Genomics Omentin: Linking Metabolic Syndrome and Cardiovascular Disease
Current Vascular Pharmacology Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients
Current Pharmaceutical Design 10 Years of SELDI: What Have we Learnt?
Current Proteomics Mechanisms Involved in Metformin Action in the Treatment of Polycystic Ovary Syndrome
Current Pharmaceutical Design Does Data Shape Moral Decision? Or Do Values Shape the Data?
Current Pediatric Reviews FXR, A Therapeutic Target for Bile Acid and Lipid Disorders
Mini-Reviews in Medicinal Chemistry The Role of Endothelin-1 in Obstructive Sleep Apnea Syndrome and Pulmonary Arterial Hypertension: Pathogenesis and Endothelin-1 Antagonists
Current Medicinal Chemistry Potential Cell Signalling Mechanisms Involved in Differential Placental Angiogenesis in Mild and Severe Pre-Eclampsia
Current Vascular Pharmacology The Failure of Immunomodulation Therapy in Heart Failure: Does the Statins “Paradigm” Prove the Rule?
Current Vascular Pharmacology Angiotensin-Converting Enzyme - New Insights into Structure, Biological Significance and Prospects for Domain-Selective Inhibitors
Current Enzyme Inhibition Biomarkers of Aspirin Resistance
Recent Patents on Biomarkers An Update on “Selenium Containing Compounds from Poison to Drug Candidates: A Review on the GPx-like Activity”
Current Chemical Biology Editorial
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Biology of Cholesterol Lowering in Atherosclerotic Plaques
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Notch Signaling in Cardiovascular Disease and Calcification
Current Cardiology Reviews Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Pharmacologically Targeting the Primary Defect and Downstream Pathology in Duchenne Muscular Dystrophy
Current Gene Therapy